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Background: Ergnovine (Erg) and Acetylcholine (Ach) is an useful agent for assessing significant coronary artery spasm (CAS). However, a 
comparison studies of the two agents are limited.
Methods: A total 113 consecutive patients (pts) without significant coronary artery disease (CAD) who underwent Erg and/ or Ach provocation test 
between May 2010 and October 2011 were enrolled. Significant CAS was defined as focal or diffuse severe transient luminal narrowing (>70%) with/
without chest pain or ST-T change on ECG. We investigated whether there are differences in clinical and angiographic characteristics according to 
intracoronary Erg or Ach provocation test.
Results: Baseline clinical characteristics were similar between the two groups except the Erg group had more male gender (69.3 vs. 31.6%, < 
0.001) and smokers (34.6 vs. 11.6%, <0.001). During the provocation test, the incidence of ischemic chest pain and ECG change were not different 
but AV block during the test was higher with Ach provocation test. More pts responded to lower Ach dose and higher Erg dose to induce significant 
CAS. Despite of similar incidence of multi-vessel involvement, the incidence of diffuse spasm was higher with Erg test (Table).
Conclusion: Both Erg and Ach were safe but Ach was more sensitive even to lower Ach dose as compared to Erg. Erg test was more associated with 
diffuse spasm whereas Ach was more associated with focal spasm.
Table. Clinical and Angiographic Parameters during Ach versus Erg Provocation Test 
Variables, n (%) Erg (n=49pts) Ach (n=60pts) P-value
Ischemic Chest Pain 34 (69.4) 45 (75.0) 0.514
EKG Change 6 (12.2) 8 (13.3) 0.866
AVB during the test 0 (0) 10 (16.6) 0.003 
coughing 0 (0) 8 (13.3) 0.008
pacing 0 (0) 2 (3.3) 0.197
Response to (Erg / Ach) dose
1 (5ug / 20ug) 0 (0) 7 (11.6) 0.013 
2 (10ug / 50ug) 8 (16.3) 21 (35.0) 0.028 
3 (25ug / 100ug) 41 (83.6) 32 (53.3) 0.001 
Multi-vessel spasm 16 (32.7) 28 (47.5) 0.119
Diffuse spasm (>30mm) 8 (16.3) 5 (8.3) < 0.001
QCA
Spasm narrowing.mm 0.60 ± 0.28 0.69 ± 0.33 0.116
Narrowing % 75.14 ± 10.42 71.89 ± 10.47 0.111
Mild (< 50%) 0 (0) 1 (1.6) 0.360
Moderate (50-70%) 11 (22.4) 20 (33.8) 0.190
Severe (>70%) 31 (63.2) 32 (54.2) 0.343
Myocardial Bridge 8 (16.3) 6 (10) 0.326
